Methyl 2-{[2-(pyridin-2-yl)-6-(trifluoromethyl)pyrimidin-4-yl]sulfanyl}acetate

Catalog No. :
ACQMDC825
CAS No. :
338418-14-7
Molecular Formula :
C13H10F3N3O2S
Molecular Weight :
329.30

IUPAC Name:methyl 2-((2-(pyridin-2-yl)-6-(trifluoromethyl)pyrimidin-4-yl)thio)acetate

Methyl 2-{[2-(pyridin-2-yl)-6-(trifluoromethyl)pyrimidin-4-yl]sulfanyl}acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$565.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-{[2-(pyridin-2-yl)-6-(trifluoromethyl)pyrimidin-4-yl]sulfanyl}acetate
IUPAC Namemethyl 2-((2-(pyridin-2-yl)-6-(trifluoromethyl)pyrimidin-4-yl)thio)acetate
MDL No.MFCD00139800
Molecular FormulaC13H10F3N3O2S
Molecular Weight329.30
SMILESO=C(OC)CSC1=NC(C2=NC=CC=C2)=NC(C(F)(F)F)=C1
InChI KeyUGMLAKAURKMFCH-UHFFFAOYSA-N
SynonymMETHYL 2-([2-(2-PYRIDINYL)-6-(TRIFLUOROMETHYL)-4-PYRIMIDINYL]SULFANYL)ACETATE;Acetic acid, 2-[[2-(2-pyridinyl)-6-(trifluoromethyl)-4-pyrimidinyl]thio]-, methyl ester
CAS No.338418-14-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQMDC825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQMDC825 route product structure diagram
    ACQMDC825338418-14-7
Inquiry

2. ACQMDC825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQMDC825 route product structure diagram
    ACQMDC825338418-14-7
Inquiry

Comments (0)